Sonoma pharmaceuticals announces expansion of its partner network for oral and dental products in the u.s. and china

Woodstock, ga.--(business wire)--sonoma pharmaceuticals, inc. (nasdaq: snoa), a global healthcare leader developing and producing patented microcyn® technology-based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that it has added salus medical as an additional distribution partner in the united states for dental care and expanded its oral and dental care li
SNOA Ratings Summary
SNOA Quant Ranking